Since ECM stiffness affects osteoblast differentiation, for example through the transcription factor YAP/TAZ,74 the collagen cross-linking activity of Loxl2 could favor bone formation in the tumor and promote the more aggressive osteoblastic phenotype. Here, LOXL2 is linked to neoplasm.